Related Experiment Videos
Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation
D Adkins1, R Brown, L T Goodnough
1Washington University School of Medicine, Department of Internal Medicine, Division of Bone Marrow Transplantation, St Louis, MO 63110, USA.
Bone Marrow Transplantation
|March 5, 1998
Abstract:
Conventional approaches to the treatment of recurrent mantle cell lymphoma (MCL) yield unsatisfactory results. We describe a patient with recurrent MCL in leukemic phase refractory to chemotherapy who was successfully treated with allogeneic bone marrow transplantation. At last follow-up 1 year post-transplant, the patient was in complete remission and had limited chronic graft-versus-host disease.